Paul Gregor
Vorstandsvorsitzender bei Rimonyx Pharmaceuticals Ltd.
Profil
Paul Gregor is the founder and the Chief Executive Officer of Romonyx Pharmaceuticals Ltd., which was founded in 2001.
He also held former positions as a Technology Director at W World Corp., a Principal at The Salk Institute for Biological Studies, Bayer Pharmaceuticals Corp., National Institutes of Health, and National Institute on Drug Abuse.
Dr. Gregor's education includes an undergraduate degree from Weizmann Institute of Science.
Aktive Positionen von Paul Gregor
| Unternehmen | Position | Beginn |
|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Vorstandsvorsitzender | 01.01.2002 |
Ehemalige bekannte Positionen von Paul Gregor
| Unternehmen | Position | Ende |
|---|---|---|
| W WORL | Technik-/Wissenschafts-/F&E-Leiter | - |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| The Salk Institute for Biological Studies | Corporate Officer/Principal | - |
| National Institute on Drug Abuse | Corporate Officer/Principal | - |
Ausbildung von Paul Gregor
| Weizmann Institute of Science | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| W WORL | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Bayer Pharmaceuticals Corp. | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| National Institute on Drug Abuse | Government |
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
